2017
DOI: 10.1016/j.redox.2017.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Adipose tissue NAD+-homeostasis, sirtuins and poly(ADP-ribose) polymerases -important players in mitochondrial metabolism and metabolic health

Abstract: Obesity, a chronic state of energy overload, is characterized by adipose tissue dysfunction that is considered to be the major driver for obesity associated metabolic complications. The reasons for adipose tissue dysfunction are incompletely understood, but one potential contributing factor is adipose tissue mitochondrial dysfunction. Derangements of adipose tissue mitochondrial biogenesis and pathways associate with obesity and metabolic diseases. Mitochondria are central organelles in energy metabolism throu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
68
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(68 citation statements)
references
References 160 publications
(342 reference statements)
0
68
0
Order By: Relevance
“…Sirtuins are multifunctional enzymes that have multiple roles in adipocyte metabolism (10,36). In particular, the nuclear localized Sirt1 protein upregulates Ucp1 and browning of WAT through Pparg (28).…”
Section: Discussionmentioning
confidence: 99%
“…Sirtuins are multifunctional enzymes that have multiple roles in adipocyte metabolism (10,36). In particular, the nuclear localized Sirt1 protein upregulates Ucp1 and browning of WAT through Pparg (28).…”
Section: Discussionmentioning
confidence: 99%
“…Then, the siRNA was transfected into cells via Lipofectamine 2000 transfection reagent according to the manufacturer's protocol [43]. After 48-96 hours, the cells were collected and the knockdown efficiency were determined via western blot analysis [44].…”
Section: The Small Rna Interference Assaymentioning
confidence: 99%
“…To demonstrate whether the JNK pathway is necessary for hyperglycaemia-mediated mitochondrial fragmentation, loss-and gain-of-function assays for the JNK pathway were performed using a pathway blocker and agonist. SP600125 (SP), a JNK pathway blocker, was added to hyperglycaemia-treated cells [46], which was used as the negative control group. Meanwhile, Anisomycin (Ani), a JNK pathway agonist, was administered to MKP1-overexpressing cells, which was used as the positive control group [47].…”
Section: Mkp1 Controls Mitochondrial Fragmentation Via Inhibiting Thementioning
confidence: 99%